6,7-Dimethoxy-1'-methyl-1H-spiro[isoquinoline-3,4'-piperidin]-4(2H)-one
95%
- Product Code: 57054
CAS:
55423-58-0
| Molecular Weight: | 290.36 g./mol | Molecular Formula: | C₁₆H₂₂N₂O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD28991782 | |
| Melting Point: | 170-174 °C | Boiling Point: | 458.7±45.0 °C(Predicted) |
| Density: | 1.21±0.1 g/cm3(Predicted) | Storage Condition: | 2-8°C |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry, where it serves as a key intermediate in the synthesis of various pharmacologically active molecules. Its structure is particularly valuable in the development of compounds targeting neurological disorders, as it can interact with specific receptors in the brain. Researchers often modify its core structure to enhance binding affinity and selectivity for therapeutic targets, making it a versatile building block in drug discovery. Additionally, its spirocyclic framework is explored for its potential in creating novel anti-inflammatory and analgesic agents, contributing to the advancement of treatments for chronic pain and inflammation-related conditions.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | £335.86 |
+
-
|
| 0.250 | 10-20 days | £610.66 |
+
-
|
| 1.000 | 10-20 days | £1,221.32 |
+
-
|
6,7-Dimethoxy-1'-methyl-1H-spiro[isoquinoline-3,4'-piperidin]-4(2H)-one
This compound is primarily utilized in the field of medicinal chemistry, where it serves as a key intermediate in the synthesis of various pharmacologically active molecules. Its structure is particularly valuable in the development of compounds targeting neurological disorders, as it can interact with specific receptors in the brain. Researchers often modify its core structure to enhance binding affinity and selectivity for therapeutic targets, making it a versatile building block in drug discovery. Additionally, its spirocyclic framework is explored for its potential in creating novel anti-inflammatory and analgesic agents, contributing to the advancement of treatments for chronic pain and inflammation-related conditions.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :